Avalon GloboCare Corp. is a healthcare innovation company focused on advanced cell-based technologies and the development of transformative treatment solutions

The firm specializes in the research, design, and commercialization of cell therapies, with a particular emphasis on addressing unmet medical needs in areas such as cancer, immunology, and regenerative medicine. By leveraging its proprietary platforms and strategic partnerships, Avalon aims to drive the next generation of cellular medicine, improving patient outcomes and enhancing the efficacy of therapies. Through its integrated approach, the company is committed to advancing the frontiers of healthcare and making a meaningful impact on global health challenges.